derinet® Switzerland
Back

17.50% p.a. Barrier Reverse Convertible on BioNTech, Novartis, Roche (Quanto CHF)

  • Valor 119434502
  • ISIN CH1194345026
  • Symbol RMAYOV
Bid (indicative)%
Nominal
Ask (indicative)%
Nominal
CurrencyCHF
Price on
Sell
Buy
  • Quanto
  • (Issuer) Callable
Novartis AGCHF 
Roche Holding AGCHF 
BioNTech SEUSD 
Please note that this is an indication.

Documents

Key data
Yield max.8.89%
Yield max. p.a.16.13%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.50% (17.50%)
Premium component16.9152%
Interest share0.5848%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing12/08/2022
First Trading Day18/08/2022
Payment date19/08/2022
Final fixing14/08/2023
Redemption21/08/2023
Sustainability feature
--

Current price information

Intraday1 week1 monthyear to dateSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 142.54USD 160.35USD 80.18
CHF 82.68CHF 80.10CHF 40.05
CHF 289.00CHF 315.00CHF 157.50

No chart available

Key data
Yield max.8.89%
Yield max. p.a.16.13%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.50% (17.50%)
Premium component16.9152%
Interest share0.5848%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing12/08/2022
First Trading Day18/08/2022
Payment date19/08/2022
Final fixing14/08/2023
Redemption21/08/2023
Sustainability feature
--
Figures
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueCHF 1,000.00
Reference currencyCHF
QuantoYes
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier50.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerBank Vontobel AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program